Epidemiological and etiopathogenetic features of mycoplasma pneumonia based on modern data of practical medicine
Abstract
Abstract: This article examines the spread and clinical features of Mycoplasma pneumoniae infection in children at the present stage, especially before and after the COVID-19 pandemic in world medical practice.
Results of the study: Mycoplasma pneumoniae, which account for 8 to 25% of all pneumonia cases. To date, more than 100 species of mycoplasmas are known, only 14 species have been isolated from humans. Mycoplasma pneumoniae is a common cause of respiratory tract infections, with community-acquired pneumonia being the main burden associated with the disease. The prevalence of refractory pneumonia caused by Mycoplasma pneumoniae (MP) is increasing. However, this microorganism can cause from 20 to 40% of community-acquired bacterial pneumonia in the general population during epidemics, and in closed populations this figure reaches 70%. M. pneumoniae can cause atypical pneumonia in 10.1% and 17.6% of cases of community-acquired pneumonia in adults and children, respectively. Recently, the number of cases of MP infection has decreased significantly due to the COVID-19 pandemic, but in the post-covid period, outbreaks of Mycoplasma pneumoniae resistant to various types of antibiotics have been noted.
Conclusion: The COVID-19 pandemic has led to a change in the circulation of respiratory pathogens around the world. Nonpharmacological interventions in response to COVID-19 have shown a preventive effect on the transmission of other respiratory viruses, as well as COVID-19. From January to November 2023, Uzbekistan also experienced a high prevalence of mycoplasma infection among children and adolescents.
About the Authors
List of references
К. Е.а, К. Д.в, и Ш. И.ю, «Клинико-эпидемиологические и иммунологические характеристики микоплазменных пневмоний (аналитический обзор)», Журнал МедиАль, вып. 1 (23), Art. вып. 1 (23), 2019.
Р. С. Александровна, Б. А.а, К. Р.с, Ш. Е.п, Я. С.б, и Ш. О.г, «Особенности внебольничной пневмонии, вызванной Mycoplasma pneumoniae: обзор литературы и результаты собственных исследований», Клиническая Микробиология И Антимикробная Химиотерапия, т. 15, вып. 1, Art. вып. 1, 2013.
H. Zhao и др., «Absolute quantification of Mycoplasma pneumoniae in infected patients by droplet digital PCR to track disease severity and treatment efficacy», Front. Microbiol., т. 14, 2023, doi: 10.3389/fmicb.2023.1177273.
N. Ishiguro и др., «Regional differences in prevalence of macrolide resistance among pediatric mycoplasma pneumoniae infections in Hokkaido, Japan», Jpn. J. Infect. Dis., т. 69, вып. 3, сс. 186–190, 2016, doi: 10.7883/yoken.JJID.2015.054.
E. Lee и Y. Y. Lee, «Predictive factors of the responses to treatment of mycoplasma pneumoniae pneumonia», J. Clin. Med., т. 10, вып. 6, сс. 1–12, 2021, doi: 10.3390/jcm10061154.
K. B. Waites, L. Xiao, Y. Liu, M. F. Balish, и T. P. Atkinson, «Mycoplasma pneumoniae from the respiratory tract and beyond», Clin. Microbiol. Rev., т. 30, вып. 3, сс. 747–809, 2017, doi: 10.1128/CMR.00114-16.
P. M. Meyer Sauteur и др., «Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions», Lancet Microbe, т. 5, вып. 2, сс. e100–e101, 2024, doi: 10.1016/S2666-5247(23)00344-0.
J. Li, H. Zhang, J. Guo, и X. Ma, «Clinical features of Mycoplasma pneumoniae pneumonia in children without fever», BMC Pediatr., т. 24, вып. 1, 2024, doi: 10.1186/s12887-023-04512-1.
E. Yacoub, I. Chniba, N. Khadraoui, B. Mlik, и B. B. A. Mardassi, «Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae», J. Vis. Exp., т. 2023, вып. 192, 2023, doi: 10.3791/64645.
G. Wang, P. Wu, R. Tang, и W. Zhang, «Global prevalence of resistance to macrolides in Mycoplasma pneumoniae: a systematic review and meta-analysis», J. Antimicrob. Chemother., т. 77, вып. 9, сс. 2353–2363, 2022, doi: 10.1093/jac/dkac170.
K. B. Waites и T. P. Atkinson, «The role of Mycoplasma in upper respiratory infections», Curr. Infect. Dis. Rep., т. 11, вып. 3, сс. 198–206, 2009, doi: 10.1007/s11908-009-0030-6.
[D. Guo и др., «Allele-specific real-time PCR testing for minor macrolide-resistant Mycoplasma Pneumoniae», BMC Infect. Dis., т. 19, вып. 1, 2019, doi: 10.1186/s12879-019-4228-4.
T. Oishi и K. Ouchi, «Recent Trends in the Epidemiology, Diagnosis, and Treatment of Macrolide-Resistant Mycoplasma pneumoniae», J. Clin. Med., т. 11, вып. 7, 2022, doi: 10.3390/jcm11071782.
C. Park, D. Lee, B. I. Kim, S. Park, G. Lee, и S. Tak, «Changes in the pattern and disease burden of acute respiratory viral infections before and during the COVID-19 pandemic», Osong Public Health Res. Perspect., т. 13, вып. 3, сс. 203–211, 2022, doi: 10.24171/J.PHRP.2022.0144.
M. Tang и др., «Comparison of respiratory pathogens in children with community-acquired pneumonia before and during the COVID-19 pandemic», BMC Pediatr., т. 23, вып. 1, 2023, doi: 10.1186/s12887-023-04246-0.
L. Bermúdez-Barrezueta и др., «Increase in severe acute respiratory infections in children during the last phase of the COVID-19 pandemic», Rev. Esp. Quimioter., т. 37, вып. 1, сс. 58–68, 2024, doi: 10.37201/req/074.2023.
L. Zhu и др., «Epidemiological characteristics of respiratory viruses in hospitalized children during the COVID-19 pandemic in southwestern China», Front. Cell. Infect. Microbiol., т. 13, 2023, doi: 10.3389/fcimb.2023.1142199.
О. С. Санақуловна, Ё. Н. Турғунбоевна, и Э. Г. Хазратовна, «Роль Mycoplasma pneumoniae в качестве этиологического агента при заболеваниях респираторного тракта», Биология И Интегративная Медицина, вып. 4, Art. вып. 4, 2017.
T. P. Atkinson и K. B. Waites, «Mycoplasma pneumoniae Infections in Childhood», Pediatr. Infect. Dis. J., т. 33, вып. 1, с. 92, янв. 2014, doi: 10.1097/INF.0000000000000171.
T. Shimizu и др., «Cytadherence of Mycoplasma pneumoniae Induces Inflammatory Responses through Autophagy and Toll-Like Receptor 4», Infect. Immun., т. 82, вып. 7, сс. 3076–3086, июл. 2014, doi: 10.1128/IAI.01961-14.
M. Naghib, M. Hatam-Jahromi, M. Niktab, R. Ahmadi, и A. Kariminik, «Mycoplasma pneumoniae and toll-like receptors: A mutual avenue», Allergol. Immunopathol. (Madr.), т. 46, вып. 5, сс. 508–513, сен. 2018, doi: 10.1016/j.aller.2017.09.021.
К. Е. Александрович, «Клинико-этиологическая характеристика внебольничной пневмонии у детей», кандидат наук, ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова» Министерства здравоохранения Российской Федерации, 2024. Просмотрено: 5 апрель 2024 г. [Онлайн]. Доступно на: https://dissercat.com/content/kliniko-etiologicheskaya-kharakteristika-vnebolnichnoi-pnevmonii-u-detei
M. S. Pm, van R. Am, и V. C, «Mycoplasma pneumoniae in children: carriage, pathogenesis, and antibiotic resistance», Curr. Opin. Infect. Dis., т. 27, вып. 3, июн. 2014, doi: 10.1097/QCO.0000000000000063.
С. А. Рачина и Р. С. Козлов, «Современные подходы к микробиологической диагностике при внебольничной пневмонии», Пульмонология, т. 0, вып. 5, Art. вып. 5, 2010.
Г. М.а и др., «Резистентная к макролидам микоплазменная инфекция у детей: концепция формирования, современные принципы диагностики и лечения», Здоровье Ребенка, т. 13, вып. 3, Art. вып. 3, 2018.
S. Pereyre, J. Goret, и C. Bébéar, «Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment», Front. Microbiol., т. 7, с. 974, 2016, doi: 10.3389/fmicb.2016.00974.
L.-S. Shan, X. Liu, X.-Y. Kang, F. Wang, X.-H. Han, и Y.-X. Shang, «Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children», World J. Pediatr., т. 13, вып. 4, сс. 321–327, авг. 2017, doi: 10.1007/s12519-017-0014-9.
J. M. Winchell и S. L. Mitchell, «Detection of mycoplasma pneumoniae by real-time PCR», Methods Mol. Biol., т. 943, сс. 149–158, 2013, doi: 10.1007/978-1-60327-353-4_10.
F. Daxboeck, R. Krause, и C. Wenisch, «Laboratory diagnosis of Mycoplasma pneumoniae infection», Clin. Microbiol. Infect., т. 9, вып. 4, сс. 263–273, 2003, doi: 10.1046/j.1469-0691.2003.00590.x.
Q.-Y. Peng и др., «Poor accuracy of single serological IgM tests in children with suspected acute Mycoplasma pneumoniae infection in Guangzhou, China», J. Med. Microbiol., т. 72, вып. 3, 2023, doi: 10.1099/jmm.0.001673.
W. Tuo и др., «Application value of antibody titres and RNA detection in the early prediction of Mycoplasma pneumoniae pneumonia in children: a retrospective study», BMC Infect. Dis., т. 23, вып. 1, 2023, doi: 10.1186/s12879-023-08161-8.
E. Lee и I. Choi, «Clinical Usefulness of Serum Lactate Dehydrogenase Levels in Mycoplasma pneumoniae Pneumonia in Children», Indian J. Pediatr., 2022, doi: 10.1007/s12098-022-04205-0.
D. Li и др., «Neutrophil-to-lymphocyte ratio as a predictor of poor outcomes of Mycoplasma pneumoniae pneumonia», Front. Immunol., т. 14, 2023, doi: 10.3389/fimmu.2023.1302702.
H. Brunner, B. Prescott, H. Greenberg, W. D. James, R. L. Horswood, и R. M. Chanock, «Unexpectedly high frequency of antibody to Mycoplasma pneumoniae in human sera as measured by sensitive techniques», J. Infect. Dis., т. 135, вып. 4, сс. 524–530, 1977, doi: 10.1093/infdis/135.4.524.
S. Choo, S.-H. Kim, и E. Lee, «Clinical significance of Mycoplasma pneumoniae specific IgM titer in children hospitalized with Mycoplasma pneumoniae pneumonia», BMC Infect. Dis., т. 22, вып. 1, 2022, doi: 10.1186/s12879-022-07456-6.
L. Huang, X. Huang, W. Jiang, R. Zhang, Y. Yan, и L. Huang, «Independent predictors for longer radiographic resolution in patients with refractory Mycoplasma pneumoniae pneumonia: A prospective cohort study», BMJ Open, т. 8, вып. 12, 2018, doi: 10.1136/bmjopen-2018-023719.
Y. Katsushima и др., «Characteristics of Mycoplasma pneumoniae infection identified on culture in a pediatric clinic», Pediatr. Int., т. 57, вып. 2, сс. 247–252, 2015, doi: 10.1111/ped.12513.